Compare BTMD & HNNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BTMD | HNNA |
|---|---|---|
| Founded | 2012 | 1989 |
| Country | United States | United States |
| Employees | N/A | 18 |
| Industry | Medicinal Chemicals and Botanical Products | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 65.8M | 78.9M |
| IPO Year | 2021 | N/A |
| Metric | BTMD | HNNA |
|---|---|---|
| Price | $2.26 | $9.89 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $2.83 | N/A |
| AVG Volume (30 Days) | ★ 392.1K | 4.6K |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 5.57% |
| EPS Growth | ★ 722.22 | N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $192,219,000.00 | N/A |
| Revenue This Year | $2.03 | N/A |
| Revenue Next Year | $6.58 | N/A |
| P/E Ratio | $37.50 | ★ $8.77 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.27 | $8.90 |
| 52 Week High | $4.75 | $13.19 |
| Indicator | BTMD | HNNA |
|---|---|---|
| Relative Strength Index (RSI) | 50.32 | 41.82 |
| Support Level | $1.99 | $9.65 |
| Resistance Level | $2.44 | $10.33 |
| Average True Range (ATR) | 0.15 | 0.14 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 30.97 | 0.00 |
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.
Hennessy Advisors Inc is an investment management company that manages and markets open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, multi-asset sectors, specialty products, and fixed income products. The company earns revenues mainly from investment advisory services and secondarily from shareholder services. Advisory services include managing each fund's portfolio in line with its investment objectives, monitoring compliance and performance, overseeing sub-advisors and other service providers, and handling marketing, distribution, and regulatory reporting. Shareholder services cover investor support and coordination with the fund service provider, with all related fees based on the funds' average daily net asset values.